CDRL S.A. (WSE:CDL)

Ligand Pharmaceuticals Ratios and Metrics

Market cap in millions PLN. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Aug 12, 2025	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	57	67	106	171	99	142
Market Cap Growth	-31.87%	-36.36%	-38.21%	73.70%	-30.44%	0.49%
Enterprise Value	89	175	219	242	211	308
Last Close Price	9.40	11.20	17.60	27.41	14.69	19.93
PE Ratio	1.09	-	8.78	5.40	-	11.21
PS Ratio	0.28	0.25	0.37	0.40	0.24	0.28
PB Ratio	0.61	0.81	1.22	2.16	1.64	1.31
P/TBV Ratio	0.66	0.89	1.92	3.52	3.32	2.07
P/FCF Ratio	1.18	4.24	-	2.97	1.51	5.99
P/OCF Ratio	1.09	3.58	-	2.82	1.39	4.22
EV/Sales Ratio	0.44	0.64	0.77	0.57	0.52	0.60
EV/EBITDA Ratio	3.59	25.02	13.84	5.66	8.10	9.95
EV/EBIT Ratio	5.65	36.10	18.20	6.13	10.40	12.79
EV/FCF Ratio	1.86	11.03	-	4.19	3.24	13.01
Debt / Equity Ratio	0.40	0.96	1.46	1.15	2.01	1.45
Debt / EBITDA Ratio	1.52	4.81	4.88	1.61	2.54	2.95
Debt / FCF Ratio	0.76	5.01	-	1.58	1.85	6.63
Asset Turnover	0.94	1.04	0.97	1.61	1.32	1.89
Inventory Turnover	0.67	0.88	0.87	1.91	1.77	2.69
Quick Ratio	0.30	0.16	0.11	0.22	0.18	0.21
Current Ratio	1.47	1.18	1.01	1.08	0.99	1.19
Return on Equity (ROE)	92.84%	4.82%	23.50%	47.62%	-49.55%	11.32%
Return on Assets (ROA)	4.35%	1.15%	2.58%	9.33%	4.11%	5.52%
Return on Capital (ROIC)	6.43%	1.61%	3.92%	14.03%	5.68%	7.30%
Return on Capital Employed (ROCE)	15.10%	5.40%	11.00%	32.60%	17.00%	11.90%
Earnings Yield	78.81%	-5.01%	11.39%	18.53%	-37.31%	8.92%
FCF Yield	85.11%	23.60%	-57.20%	33.71%	66.20%	16.69%
Dividend Yield	-	-	-	2.74%	-	-
Payout Ratio	-	-	37.42%	37.89%	-	41.22%
Buyback Yield / Dilution	-	-	-	0.17%	0.14%	0.38%
Total Shareholder Return	-	-	-	2.91%	0.14%	0.38%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.